ConnectiveRx

When cost stands between a patient and their medication, everything you've worked for is on the line. That's why this recognition means so much. ConnectiveRx was named the #1 Affordability Service provider in independent McKinsey research, earning the highest Net Promoter Score in the industry. For the teams focused on getting therapies into patients' hands, this matters because affordability is where access often breaks down: ✔️ Out-of-pocket costs are a leading driver of abandonment ✔️ Higher costs mean lower adherence and weaker outcomes ✔️ The right copay support can keep patients on therapy from day one When affordability works, patients start therapy, stay on it, and your brand delivers on its promise. See the full announcement ➡️ https://hubs.li/Q04pwgG_0 #PatientAccess #MarketAccess #Pharma #CopaySupport

Prescribers spend nearly 6 hours a day inside the EHR. It's the backbone of their practice—not a channel they wander into. You can spend years building awareness before a single script is written. But awareness isn't activation. The real decision happens the moment a prescriber opens a patient's chart. A few numbers that make the case: ✅ Prescribers spend 5.8 hours a day in the EHR ✅ 57% of providers won't leave the EHR to find affordability info ✅ CRx data shows that EHR messaging aligned to first fill behavior reduces abandonment by 13%–15% Treat the EHR as the bottom of the funnel, not an afterthought. Meet prescribers where decisions actually close ➡️ https://hubs.li/Q04mpmqv0 #PharmaMarketing #HCPEngagement #PointOfCare

You spent MILLIONS on copay programs and hubs. So why do they sit unused? Because at the exact moment an Rx gets written, the prescriber often has NO idea that support exists. Point-of-Care isn't just another channel. It's how your upstream spend finally gets seen and where prescribing happens. Show up there, and: 🔹Coverage you funded gets used 🔹Copay help reaches patients before they walk away 🔹Your hub gets the call it was built for You've already made the investment. Make sure it shows up ➡️ https://hubs.li/Q04p1j2Z0 #PatientAccess #PharmaMarketing #MarketAccess #EHR

A minimum viable launch is a performance strategy, not a shortcut. The programs that actually move patients to therapy quickly share one thing in common: they built access into the plan from the start, not after it. A minimum viable launch isn't about doing less. It's about doing the right things first: 🔸 Speed matters. But speed without discipline triggers bottlenecks faster 🔸 Operational clarity so next steps for every coverage outcome are clear 🔸 Thoughtful automation. Let tech earn its spot. 🔸 And, defined milestones because go-live isn't success. What happens after it is. If you're building, reworking, or rethinking a patient access program, this one's worth your time ➡️ https://hubs.li/Q04km1s40 #MarketAccess #SpecialtyPharma #BenefitsVerification #PriorAuthorization

What if your GTN forecast is built on numbers that won't hold still? Accumulators, maximizers, and pharmacy misuse don't drain your copay dollars at a fixed rate—the leakage moves. That's the part many forecasts miss. During our recent GTN webinar, Chris Dowd & Patrick R Coyle, MBA bring a finance lens you don't often hear in copay conversations: payer and pharmacy leakage demand ongoing attention, not a one-time estimate. By revisiting GTN assumptions, you protect both patient access and your brand's bottom line. Get instant access and watch the full discussion today ➡️ https://hubs.li/Q04n3QYJ0 #GrossToNet #MarketAccess #CopayAssistance #PatientAccess

A struggling hub program doesn't mean you invested in the wrong therapy. It often means you picked the wrong partner. Here's something we've learned: 65% of our active hub programs started somewhere else. Brands came to us looking for a turnaround, and they stayed. A few numbers behind that: ⚡ 95% of transitioned brands remain long-term partners ⚡ 100% of them add more of our services over time ⚡ Switching happens smoothly, with #PatientAccess protected throughout A rocky transition is the fear that keeps most teams stuck with an underperforming hub. We get it. That's why we lead with continuity first, then raise the bar on speed and support. Connect with our hub transition experts and see what a smoother path looks like ➡️ https://hubs.ly/Q04lrM4-0 #HubServices #MarketAccess #Pharma #SpecialtyPharmacy

Who's in the room when you plan your affordability program? For most launches, it's usually patient services, market access, and the team running your copay program. But there's often one key voice missing from the table—finance. In this clip from our recent GTN webinar, Chris Dowd & Patrick R Coyle, MBA (former pharma CFO), explain that when finance is part of the conversation, you get clarity on where responsibilities overlap and a shared understanding of what success actually looks like. The result? More realistic expectations and far fewer "we didn't see that coming" moments after launch. Register now for instant access to the full conversation ➡️ https://hubs.li/Q04n4btn0 #GrossToNet #MarketAccess #CopayAssistance #PatientAccess

Switching hub vendors shouldn't feel like a disruption. For patients and providers, it should feel like nothing changed at all. Our SVP of Implementation, Kristine McGaughey, shared that perspective in Pharmaceutical Commerce's latest hub roundtable. A few ideas worth sitting with: 🔹 When done right, hub transitions are invisible to patients and providers. (More than 65% of our hub programs came from another vendor, and 95% have stayed with us for 5+ years.) 🔹 Technology should empower the human touch, not replace it. The goal is to remove friction, not build new barriers. 🔹 Hybrid hub models are on the rise. Manufacturers own the strategy and lean on hub partners for execution, scale, and specialized expertise, so they can stay focused on their mission. Kristine joined other patient services experts for the full conversation. It's a thoughtful read for anyone working to keep patients connected to their therapies. Read the roundtable (link in comments). #HubServices #PatientAccess #MarketAccess #PatientSupport

Does the push for AI in your hub have you stuck between cutting costs and protecting program quality? It’s a common challenge for access leaders: balancing speed and efficiency with safeguarding the patient and provider experience. The real value of AI in PSPs lies in asking the right questions: ▶️ Will this improve patient outcomes or just reduce costs? ▶️ How will it support adherence, PA success, and lower abandonment? ▶️ When does the model escalate to a human touchpoint? Discover the 8 essential questions every access team should ask to ensure AI adoption drives real value for patients and programs ➡️ https://hubs.li/Q04gG2420 #PatientAccess #PharmaAI #PatientSupportServices #MarketAccess

Your brand can spend years—and sometimes nine figures—building awareness before a single script is written. But awareness isn't activation. In a new PM360 Magazine article, Maria Giampino O'Mara, SVP Business Development and Sales Ops, argues most EHR campaigns aren't reaching their full potential. Two numbers worth sitting with: 🔸Prescribers spend 5.8 hours a day in the EHR. It's the backbone of their practice, not a place they wander into. 🔸57% of providers won't leave the EHR to find affordability info. If your copay program lives on a brand site, they may never see it. The shift is simple: treat the EHR as your bottom-of-the-funnel tactic, not an afterthought ➡️ https://hubs.li/Q04mnVJQ0 #PharmaMarketing #HCPEngagement #PointOfCare